tiprankstipranks
bluebird bio (BLUE)
NASDAQ:BLUE
Holding BLUE?
Track your performance easily

Bluebird Bio (BLUE) Ownership - Who Owns Bluebird Bio?

2,756 Followers

Bluebird Bio (BLUE) Ownership Overview

0.82%10.76%3.41%10.39%74.62%
3.41% Other Institutional Investors
10.39% ETFs
74.62% Public Companies and Individual Investors
The ownership structure of Bluebird Bio (BLUE) stock is a mix of institutional, retail, and individual investors. Approximately 24.55% of the company’s stock is owned by Institutional Investors, 0.82% is owned by Insiders, and 74.62% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 04, 2024
Thomas J Klima
Chief Commercial & Operating Officer
xxxxxxxxxxxxx
$3719
Mar 05, 2024
xxxxxxxxxxxxx
$10290
Mar 05, 2024
Thomas J Klima
Chief Commercial & Operating Officer
xxxxxxxxxxxxx
$6951
Mar 05, 2024
Andrew Obenshain
President & Ceo,director
xxxxxxxxxxxxx
$9264

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,072,400Institution5.18%3,636,136
9,123,142Institution4.69%3,293,454
9,053,861Institution4.66%3,268,444
2,226,000Institution1.14%803,586
2,205,337Institution1.13%796,127
2,135,449Institution1.10%770,897
2,000,000Institution1.03%722,000
1,500,000Institution0.77%541,500
969,336Institution0.50%349,930
915,820Institution0.47%330,611

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
9,053,861Institution4.66%3,268,444
2,226,000Institution1.14%803,586
2,205,337Institution1.13%796,127
2,135,449Institution1.10%770,897
915,820Institution0.47%330,611
883,022Institution0.45%318,771
796,491Institution0.41%287,533
636,031Institution0.33%229,607
553,060Institution0.28%199,655
206,648Institution0.11%74,600

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,862,463Institution3.01%2,720,183
5,335,848Institution2.74%1,929,976
3,191,398Institution1.64%1,480,809
1,888,599Institution0.97%683,106
1,272,871Institution0.65%460,397
873,584Institution0.45%405,343
437,446Institution0.22%158,224
241,368Institution0.12%84,503
131,145Institution0.07%60,851
108,026Institution0.06%37,820

FAQ

Who Owns bluebird bio (BLUE)?
According to the latest TipRanks data, approximately 3.41% of the company's stock is held by institutional investors, 0.82% is held by insiders, and 74.62% is held by retail investors.
    What percentage of bluebird bio (BLUE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.41% of bluebird bio (BLUE) stock is held by institutional investors.
      What percentage of bluebird bio (BLUE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 74.62% of bluebird bio (BLUE) stock is held by retail investors.
        Who owns the most shares of bluebird bio (BLUE)?
        Vanguard owns the most shares of bluebird bio (BLUE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis